Cullinan Therapeutics
CGEM
#6903
Rank
C$0.61 B
Marketcap
$10.54
Share price
-1.07%
Change (1 day)
-54.30%
Change (1 year)

EPS for Cullinan Therapeutics (CGEM)

EPS in 2024 (TTM): -$5.41

According to Cullinan Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.70. In 2022 the company made an earnings per share (EPS) of $3.55 an increase over its 2021 EPS that were of -$2.14.

EPS history for Cullinan Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$5.41
2022$3.55-266.48%
2021-$2.14